COVID-19 is having a catastrophic impact on the most vulnerable communities around the world and is threatening decades of progress in the fight against HIV, TB and malaria. The Global Fund works with partners, countries and communities to fight COVID-19, adapt lifesaving HIV, TB and malaria programs, and reinforce fragile systems for health. Through our COVID-19 Response Mechanism (C19RM ), the Global Fund is now the primary channel for providing grant support to low- and middle-income countries for COVID-19 tests, treatments (including medical oxygen), personal protective equipment (PPE) and critical elements of health system strengthening.
Global Fund support to fight COVID-19:
As of 14 September 2021
- Total funds approved to support the Global Fund's COVID-19 response:
US$3.6 billion
- Countries who received Global Fund support for COVID-19:
107 countries & 18 multicountry programs
- C19RM 2021 funds raised to date:
US$3.75 billion
- C19RM 2021 fundraising target:
US$10 billion
- Funding Approved for the COVID-19 Response: (Excel | PDF)
* Full list of countries with approved funding is available here. These numbers are only updated once countries have been notified of their funding approval.
How countries are using COVID-19 funding:
As of 10 September 2021
72%: Reinforcing national COVID-19 response: including purchasing critical tests, treatments, oxygen and medical supplies; protecting front-line health workers with training and PPE like gloves and masks; and supporting control and containment interventions, including test, trace and treat/isolate.
16%: Mitigating COVID-19 impact on HIV, TB and malaria programs: including by delivering medicines, mosquito nets and critical supplies door to door, protecting community health workers and providing support and prevention services via digital platforms.
12%: Making urgent improvements to health and community systems to help fight COVID-19, HIV, TB and malaria, including by reinforcing supply chains, laboratory networks and community led response systems.
